792 followers
RT @AnnSurgOncol: MAY ISSUE: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with #GastricCancer After D2 Lymph Node Dissec…
2,353 followers
RT @AnnSurgOncol: MAY ISSUE: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with #GastricCancer After D2 Lymph Node Dissec…
507 followers
RT @AnnSurgOncol: MAY ISSUE: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with #GastricCancer After D2 Lymph Node Dissec…
241 followers
RT @AnnSurgOncol: MAY ISSUE: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with #GastricCancer After D2 Lymph Node Dissec…
4,418 followers
RT @AnnSurgOncol: MAY ISSUE: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with #GastricCancer After D2 Lymph Node Dissec…
4,316 followers
RT @AnnSurgOncol: MAY ISSUE: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with #GastricCancer After D2 Lymph Node Dissec…
639 followers
RT @AnnSurgOncol: MAY ISSUE: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with #GastricCancer After D2 Lymph Node Dissec…
14,590 followers
MAY ISSUE: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with #GastricCancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study. https://t.co/dRyRBJrv9r
276 followers
治癒切除、D2郭清したstsge II,III胃癌を対象に術後補助ケモとしてXELOXもしくはS-1をやった場合の3yDFSを後ろ向きに比較。セレクションバイアスを最小化するために傾向スコアを用いている。stage IIIB,IIICに於ける再発リスクはS-1群がXELOX群の２倍だったそう。 https://t.co/Wfog5SWcY1
213 followers
Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study https://t.co/LWVEyhn9Ji